Skip to main content

Articles

Aims and scope

Molecular Neurodegeneration (MN) is an open access, peer-reviewed journal dedicated to publishing groundbreaking research in the field of neurodegeneration. Our mission is to foster a deeper understanding of neurodegenerative diseases, including but not limited to Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, glaucoma, and macular degeneration, to inform novel diagnosis and effective therapy. We aim to publish innovative studies addressing the complex mechanisms of neurodegenerative disorders at the molecular, cellular, and systems levels, with a strong emphasis on broad impact and scientific rigor.

Official journal of

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 14.9
    5-year Journal Impact Factor: 16.7
    Source Normalized Impact per Paper (SNIP): 2.566
    SCImago Journal Rank (SJR): 5.205

    Speed 2023
    Submission to first editorial decision (median days): 26
    Submission to acceptance (median days): 150

    Usage 2023
    Downloads: 1,584,169
    Altmetric mentions: 2,567

Contact the Managing Editorial Team

Hongmei Li 

Lucy Job 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline